An inhibitory antibody blocks interactions between components of the malarial invasion machinery

Area of Science:

• Parasitology
• Immunology
• Vaccine Development

Background:

• Apicomplexan parasites like Plasmodium spp. and Toxoplasma gondii invade host cells via protein discharge from micronemes and rhoptries.
• The apical membrane antigen 1 (AMA1) complex, including AMA1, rhoptry neck proteins, and Ts4705, is vital for host cell invasion, localizing to the moving junction.
• Antibodies targeting AMA1 are protective, making AMA1 a significant malaria vaccine candidate.

Purpose of the Study:

• To investigate the conservation of the AMA1 complex in Plasmodium falciparum.
• To understand the interaction between P. falciparum AMA1 (PfAMA1) and its partner proteins within the invasion complex.
• To elucidate the mechanism by which anti-AMA1 antibodies inhibit parasite invasion.

Main Methods:

• Comparative analysis of AMA1 complex conservation between Toxoplasma and Plasmodium.
• Characterization of monoclonal antibody (mAb) 4G2 binding to PfAMA1 in the presence and absence of partner proteins.
• Site-directed mutagenesis to identify key residues involved in PfAMA1 complex formation, specifically focusing on Tyr251.

Main Results:

• The AMA1 complex identified in Toxoplasma is conserved in Plasmodium falciparum.
• The invasion-inhibitory mAb 4G2, targeting PfAMA1, is unable to bind when PfAMA1 is complexed with its partners.
• A single conserved residue, Tyr251 in PfAMA1, is essential for complex formation and located near the mAb 4G2 epitope.

Conclusions:

• The findings demonstrate the conservation of the AMA1 complex in P. falciparum, highlighting its role in host cell invasion.
• The study proposes that mAb 4G2 inhibits invasion by blocking PfAMA1's interaction within the invasion complex, mediated by Tyr251.
• These insights are valuable for the rational design of subunit malaria vaccines based on PfAMA1.